UA Finance header Logo
Apple Inc.‪$ 333.18‬-7.24‪-2.13%‬Alphabet Inc. (google)‪$ 352.87‬4.58‪+1.31%‬Microsoft Corp.‪$ 531.50‬8.89‪+1.70%‬Tesla, Inc.‪$ 386.17‬11.17‪+2.98%‬Bitcoin‪$ 83,079.81‬1,325.36‪+1.62%‬ETH/USD‪$ 2,490.81‬16.01‪+0.65%‬Gold‪$ 4,189.58‬57.66‪+1.40%‬Silver‪$ 61.01‬1.80‪+3.05%‬Crude Oil‪$ 90.62‬0.05‪+0.05%‬Natural Gaz‪$ 3.22‬0.08‪+2.48%‬Al Rajhi Company for Cooperative Insurance‪SAR 49.90‬-0.90‪-1.77%‬SpaceX‪$ 161.60‬1.03‪+0.64%‬
Regeneron Pharmaceuticals, Inc. Logo

Regeneron Pharmaceuticals, Inc. (REGN)

NASDAQ

Currency in USD
742.12
+3.40 (+0.46%)

Real-time Data

01:30 PM

Day's Range

734.18
753.68

52 wk Range

541.00
859.34

Profile - REGN - Regeneron Pharmaceuticals, Inc.

Profile

Mic Code

XNGS

Sector

Healthcare

Industry

Biotechnology

Employees

15.41K

https://www.regeneron.com

Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, develops, manufactures, and commercializes medicines for people with serious diseases. Its portfolio spans treatments in eye care, immunology, oncology, cardiovascular and metabolic disease, infectious disease, hematology, and rare disorders. The company is known for combining laboratory research, clinical development, and in-house manufacturing to advance biologic therapies and antibody-based medicines. Regeneron also works on product candidates across multiple therapeutic areas, supporting a broad drug pipeline alongside its marketed medicines. Regeneron Pharmaceuticals, Inc. plays an important role in the healthcare market through its focus on specialty therapies designed for complex and often chronic medical conditions.

Profile Details

Type

Common Stock

Address

777 Old Saw Mill River Road

City

Tarrytown

State

NY

Zip

10591-6707

Country

United States

Phone

914 847 7000

Key Executives - REGN - Regeneron Pharmaceuticals, Inc.

Key executives

NamePositionAgePay
Dr. Leonard S. Schleifer M.D., Ph.D.Co-Founder, President, CEO & Co-Chairman727.28M
Mr. Rajesh AhujaSenior Vice President of Quality Assurance & Operations--
Mr. Ryan CroweSenior Vice President of Investor Relations & Strategic Analysis--
Mr. Ryan SteinbergerExecutive VP, Chief Digital & Technology Officer--
Ms. Melissa LoznerSenior VP & Chief Compliance Officer--
Dr. George D. Yancopoulos M.D., Ph.D.Co-Founder, President, Chief Scientific Officer & Co-Chairman656.94M
Mr. Joseph J. LaRosa J.D.Executive VP, General Counsel & Secretary662.95M
Mr. Daniel P. Van PlewExecutive VP and GM of Industrial Operations & Product Supply522.03M
Dr. Andrew J. Murphy Ph.D.Executive VP of Research & Co-Chief Scientific Officer671.72M
Mr. Christopher R. Fenimore CPAExecutive VP of Finance & CFO541.48M

Cross Listings - REGN - Regeneron Pharmaceuticals, Inc.

Also listed on

The same company trading on other exchanges.

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.